- Report of Foreign Issuer (6-K)

---

---

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

 

May 7, 2012

Commission File No.: 001-34830

 

D. MEDICAL INDUSTRIES LTD.

(Translation of registrant’s name into English)

3 HaSadna St.

Tirat Carmel

39026

Israel

 (Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x Form 40-F o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): _____.

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): _____.

 

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Act of 1934.

 

Yes o No x

D. Medical Industries Ltd. (the " Company ") announces that Mr. Shai Beilis has resigned from his position as a director of the Company. Mr. Beilis notified the Company that his decision to resign came in light of some new commitments he undertook, as well as the Company's recent strategic reorganization and its announced plan to reduce the size of its board of directors in order to decrease its ongoing cash burn. The Company accepted his resignation and thanked Mr. Beilis for his significant contribution to the Company, as well as his willingness to resign in order to assist the Company in reducing the size of its board of directors.

 

 

 

---

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: May 7, 2012

D. MEDICAL INDUSTRIES LTD. (Registrant)   By:   /s/ Amir Loberman —————————————— Amir Loberman Chief Financial Officer

 

---

---